{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T07:50:31Z","timestamp":1725954631182},"reference-count":28,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2009,5,27]],"date-time":"2009-05-27T00:00:00Z","timestamp":1243382400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Investigation"],"published-print":{"date-parts":[[2009,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Background\u2002<\/jats:bold> Although amiodarone plus angiotensin II receptor blockers (ARBs) and catheter ablation may improve sinus rhythm maintenance of paroxysmal atrial fibrillation (AF), their clinical efficacies have not been compared. This prospective cohort study was designed to compare clinical efficacy of catheter ablation and amiodarone plus losartan on sinus rhythm maintenance in patients with paroxysmal AF.<\/jats:p><jats:p><jats:bold>Materials and methods\u2002<\/jats:bold> A total of 240 patients with paroxysmal AF were assigned to four groups. CPVA group (<jats:italic>n\u2003=<\/jats:italic>\u200360) was treated with circumferential pulmonary vein ablation (CPVA), SPVI group (<jats:italic>n<\/jats:italic>\u2003=\u200360) with segmental pulmonary vein isolation, AMIO group (<jats:italic>n<\/jats:italic>\u2003=\u200360) with amiodarone and AMIO\u2003+\u2003LO group (<jats:italic>n<\/jats:italic>\u2003=\u200360) with amiodarone plus losartan. The endpoint was documented recurrence of AF\u2003&gt;\u200330\u2003s by Holter or conventional 12\u2010lead ECG in the 1\u2010year follow\u2010up period.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> During 12\u2003months of follow\u2010up, the primary end point was reached in 28 patients in CPVA group, 14 patients in SPVI group, 25 patients in AMIO group and 13 patients in AMIO\u2003+\u2003LO group, respectively. The sinus rhythm in SPVI and AMIO\u2003+\u2003LO group were significant higher than that in CPVA and AMIO group (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030\u00b701 and 0\u00b7025), and no difference between CPVA and AMIO group. The maintenance rate of sinus rhythm in SPVI group was similar to that in AMIO\u2003+\u2003LO group.<\/jats:p><jats:p><jats:bold>Conclusions\u2002<\/jats:bold> This study demonstrates that segmental pulmonary vein isolation in preventing AF recurrence is similar to amiodarone plus losartan, but it is superior to CPVA and amiodarone alone in patients with paroxysmal AF. Larger multicentre studies are needed to confirm its long\u2010term outcomes.<\/jats:p>","DOI":"10.1111\/j.1365-2362.2009.02160.x","type":"journal-article","created":{"date-parts":[[2009,5,27]],"date-time":"2009-05-27T10:14:19Z","timestamp":1243419259000},"page":"657-663","source":"Crossref","is-referenced-by-count":2,"title":["Catheter ablation vs. amiodarone plus losartan for prevention of atrial fibrillation recurrence in patients with paroxysmal atrial fibrillation"],"prefix":"10.1111","volume":"39","author":[{"given":"X.","family":"Lan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z.","family":"Ling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Zrenner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,7,3]]},"reference":[{"key":"e_1_2_8_2_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.102.20.2463"},{"key":"e_1_2_8_3_2","doi-asserted-by":"publisher","DOI":"10.1161\/hc0902.104712"},{"key":"e_1_2_8_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(02)01972-1"},{"key":"e_1_2_8_5_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000095796.45180.88"},{"key":"e_1_2_8_6_2","doi-asserted-by":"publisher","DOI":"10.1161\/hc4601.098517"},{"key":"e_1_2_8_7_2","first-page":"1852","article-title":"ACC\/AHA\/ESC guidelines for the management of patients with atrial fibrillation","volume":"22","author":"A report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology","year":"2001","journal-title":"Eur Heart J"},{"key":"e_1_2_8_8_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.101.22.2612"},{"key":"e_1_2_8_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(00)00611-2"},{"key":"e_1_2_8_10_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.101.23.2678"},{"key":"e_1_2_8_11_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000022665.18619.83"},{"key":"e_1_2_8_12_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.100.4.376"},{"key":"e_1_2_8_13_2","first-page":"179","article-title":"Efficacy of combine treatment of perindopril and diltiazem for paroxysmal atrial fibrillation","volume":"17","author":"Yin Y","year":"2003","journal-title":"Chin J Cardiac Pacing Electrophysiol"},{"key":"e_1_2_8_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1071-9164(05)80004-1"},{"key":"e_1_2_8_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8167.2008.01299.x"},{"key":"e_1_2_8_16_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000144459.37455.EE"},{"key":"e_1_2_8_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(03)00577-1"},{"key":"e_1_2_8_18_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.293.21.2634"},{"key":"e_1_2_8_19_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehi583"},{"key":"e_1_2_8_20_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa050955"},{"key":"e_1_2_8_21_2","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1093\/eurheartj\/ehl135","article-title":"Prospective randomized study comparing amiodarone vs. amiodarone plus losartan vs. amiodarone plus perindopril for the prevention of atrial fibrillation recurrence in patients with lone paroxysmal atrial fibrillation","volume":"27","author":"Yin Y","year":"2006","journal-title":"Eur Heart J"},{"key":"e_1_2_8_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2005.01.022"},{"key":"e_1_2_8_23_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.92.7.1954"},{"key":"e_1_2_8_24_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.94.11.2968"},{"key":"e_1_2_8_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(97)00455-5"},{"key":"e_1_2_8_26_2","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1161\/01.CIR.101.22.2612","article-title":"Angiotensin \u03b1 antagonist prevents electrical remodeling in atrial fibrillation","volume":"101","author":"Hideko N","year":"2000","journal-title":"Circulation"},{"key":"e_1_2_8_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2004.10.068"},{"key":"e_1_2_8_28_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200003303421302"},{"key":"e_1_2_8_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(98)00078-2"}],"container-title":["European Journal of Clinical Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2362.2009.02160.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2362.2009.02160.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T21:31:28Z","timestamp":1697232688000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2362.2009.02160.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7,3]]},"references-count":28,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["10.1111\/j.1365-2362.2009.02160.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2362.2009.02160.x","archive":["Portico"],"relation":{},"ISSN":["0014-2972","1365-2362"],"issn-type":[{"value":"0014-2972","type":"print"},{"value":"1365-2362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7,3]]}}}